Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
52,953 Cancer
clinical trials

Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
St. Luke's Hospital
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
Cancer Centers of Southwest Oklahoma
mi
from
Lawton, OK
Click here to add this to my saved trials
Breast Cancer Clinical Trial
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Status: Enrolling, Phase
Updated: 12/31/1969
Texas Oncology-Plano West
mi
from
Plano, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
Status: Enrolling, Phase II
Updated: 6/26/2017
Henry Ford Hospital
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
Status: Enrolling, Phase II
Updated: 6/26/2017
NRG Oncology
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Charleston, SC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Cleveland, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Local Institution
mi
from
Orange, CA
Click here to add this to my saved trials
Oncology Clinical Trial
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Sarah Cannon Research Institute Tennessee Oncology
mi
from
Nashville, TN
Click here to add this to my saved trials
Solid Tumor Clinical Trial
SBRT + PD-1/PDL-1 Inhibiting Therapy for Advanced Solid Tumors After Dz Contro on PD-1/PDL-1 Tx
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Trial of H3B-6545, in Women With Locally Advanced or Metastatic Estrogen Receptor-positive, HER2 Negative Breast Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Univ of North Carolina
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of California
mi
from
San Francisco, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
University of Florida - Jacksonville
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
Dartmouth University
mi
from
Lebanon, NH
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Percutaneous vs. Endoscopic Drainage of Suspected Klatskin Tumors
Status: Enrolling
Updated: 3/22/2018
Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Pembrolizumab in Combination With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation and ALK Positive NSCLC (Non-Small Cell Lung Cancer) With Progressive Disease Following Prior Tyrosine Kinase Inhibitors (TKIs)
Status: Enrolling, Phase II
Updated: 12/31/1969
Barbara Ann Karmanos Cancer Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
Non-Small Cell Lung Cancer Clinical Trial
Pembrolizumab in Combination With Platinum-based Doublet Chemotherapy in Patients With EGFR Mutation and ALK Positive NSCLC (Non-Small Cell Lung Cancer) With Progressive Disease Following Prior Tyrosine Kinase Inhibitors (TKIs)
Status: Enrolling, Phase II
Updated: 12/31/1969
Sarah Cannon
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
An Open-Label Pharmacokinetics and Safety Study of Talazoparib
Status: Enrolling, Phase I
Updated: 12/31/1969
Karmanos Cancer Institute Weisberg Cancer Treatment Center
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Colorectal Cancer Metastatic Clinical Trial
Study of Durvalumab and Tremelimumab After Radiation for Microsatellite Stable Metastatic Colorectal Cancer Progressing on Chemotherapy
Status: Enrolling, Phase II
Updated: 12/31/1969
UF Health Shands Cancer Hospital
mi
from
Gainesville, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Winship Cancer Institute at Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Esophageal Neoplasms Clinical Trial
First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
Status: Enrolling, Phase III
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Esophageal Neoplasms Clinical Trial
First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)
Status: Enrolling, Phase III
Updated: 12/31/1969
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Adult Solid Tumor Clinical Trial
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Status: Enrolling, Phase
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Adult Solid Tumor Clinical Trial
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Status: Enrolling, Phase
Updated: 12/31/1969
Banner MD Anderson Cancer Center
mi
from
Gilbert, AZ
Click here to add this to my saved trials
Adult Solid Tumor Clinical Trial
CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2
Status: Enrolling, Phase
Updated: 12/31/1969
Tallahassee Memorial Cancer Center
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy
Status: Enrolling, Phase I
Updated: 12/31/1969
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Pancreatic Cancer Clinical Trial
Diet and Exercise After Pancreatic Cancer
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of MK-2118 Administered as Intratumoral Injection as Monotherapy and in Combination With Pembrolizumab (MK-3475) or by Subcutaneous Injection in Combination With Pembrolizumab in the Treatment of Adults With Advanced/Metastatic Solid Tumors or Lymphomas (MK-2118-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Ex-vivo Investigation of Beta Probe for Prostate Cancer Resection
Status: Enrolling
Updated: 8/22/2017
Indiana University Health Hospital
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
University of Colorado Hospital
mi
from
Aurora, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Carolinas Medical Center / Levine Cancer Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Margaret R Pardee Memorial Hospital
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Sutter Medical Center Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Sanford USD Medical Center - Sioux Falls
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
The University of Arizona Cancer Center - North Campus
mi
from
Tucson, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Reading Hospital
mi
from
West Reading, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Radiation Therapy With Durvalumab or Cetuximab in Treating Patients With Locoregionally Advanced Head and Neck Cancer Who Cannot Take Cisplatin
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Via Christi Regional Medical Center
mi
from
Wichita, KS
Click here to add this to my saved trials
Biliary Tract Neoplasms Clinical Trial
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Biliary Tract Neoplasms Clinical Trial
Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Status: Enrolling, Phase I
Updated: 12/31/1969
Holy Cross Hospital
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Vermont Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Status: Enrolling, Phase I
Updated: 12/31/1969
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Oklahoma Health Sciences Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Status: Enrolling, Phase I
Updated: 12/31/1969
St. Joseph Heritage Healthcare
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Advanced Solid Tumors Clinical Trial
A Phase Ib Study to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of Avelumab in Combination With M9241(NHS-IL12) (JAVELIN IL-12)
Status: Enrolling, Phase I
Updated: 12/31/1969
Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI Therapy
Status: Enrolling, Phase
Updated: 12/31/1969
University of Colorado Cancer Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
UCSF Medical Center-Mission Bay
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Madigan Army Medical Center
mi
from
Tacoma, WA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Joseph's Hospital/Children's Hospital-Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
Metastatic Pancreatic Adenocarcinoma Clinical Trial
Safety and Efficacy of APX005M With Gemcitabine and Nab-Paclitaxel With or Without Nivolumab in Patients With Previously Untreated Metastatic Pancreatic Adenocarcinoma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Status: Enrolling, Phase II
Updated: 12/31/1969
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Nemours Children's Clinic
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
To Evaluate the Safety, Tolerability, and Pharmacokinetics of GDC-0077 Single Agent in Participants With Solid Tumors and in Combination With Endocrine and Targeted Therapies in Participants With Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Validation Study of Pediatric Patient-Reported Outcomes
Status: Enrolling, Phase
Updated: 12/31/1969
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
Fulvestrant, Palbociclib and Erdafitinib in ER+/HER2-/FGFR-amplified Metastatic Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Carcinoid Tumors Clinical Trial
A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
Status: Enrolling, Phase II
Updated: 12/31/1969
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
A Study Comparing the Combination of Nivolumab and Ipilimumab Versus Placebo in Participants With Localized Renal Cell Carcinoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Highland Oncology Group
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Myelodysplastic Syndrome Clinical Trial
Safety, Clinical Activity, Pharmacokinetics (PK) and Pharmacodynamics Study of GSK2879552, Alone or With Azacitidine, in Subjects With High Risk Myelodysplastic Syndromes (MDS)
Status: Enrolling, Phase II
Updated: 9/28/2017
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Adoptive Cellular Therapy Using Autologous T Cells Transduced With Lentivirus to Express a CD33 Specific Chimeric Antigen Receptor in Patients With Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Levine Cancer Institute - Ballantyne
mi
from
Charlotte, NC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Froedtert Hospital, Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Carolina Urologic Research Center
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Weill Cornell Medical Center/New York Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Virginia Oncology Associates
mi
from
Norfolk, VA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Levine Cancer Institute-Rock Hill
mi
from
Rock Hill, SC
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Sharp Memorial Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Effects of Apalutamide Plus LHRH Agonist or Apalutamide Plus Abiraterone Acetate Plus LHRH Agonist for Six Months for Prostate Cancer Patients at High Risk for Recurrence
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Status: Enrolling, Phase
Updated: 12/31/1969
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology- Denton South
mi
from
Denton, TX
Click here to add this to my saved trials
Metastatic Breast Cancer Clinical Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Texas Oncology - Memorial City
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Therapy for Progressive and/or Refractory Hematologic Malignancies
Status: Enrolling, Phase I, II
Updated: 1/11/2018
Oncology of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Consolidation Therapy in Patients With Metastatic Solid Malignancies
Status: Enrolling, Phase I, II
Updated: 1/11/2018
Oncology of San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
University Cancer and Blood Center LLC
mi
from
Athens, GA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Overlake Medical Center
mi
from
Bellevue, WA
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Regional Cancer Care Associates
mi
from
East Brunswick, NJ
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Cancer and Hematology Centers of Western Michigan
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Healthcare System
mi
from
Hollywood, FL
Click here to add this to my saved trials
Breast Cancer Clinical Trial
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC
Status: Enrolling, Phase III
Updated: 12/31/1969
Oncology Consultants
mi
from
Houston, TX
Click here to add this to my saved trials
1 … 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 … 530